摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(coumarin-7-yloxy)-2-methyl-2(E)-butenal | 78957-45-6

中文名称
——
中文别名
——
英文名称
4-(coumarin-7-yloxy)-2-methyl-2(E)-butenal
英文别名
(E)-4-(2-oxo-2H-chromen-7-yloxy)-2-methyl-2-butenal;(E)-2-methyl-4-(2-oxo-2H-1-benzopyran-7-yloxy)but-2-enal;7(3'-Formylbut-2'-enoxy)coumarin;(E)-2-methyl-4-(2-oxochromen-7-yl)oxybut-2-enal
4-(coumarin-7-yloxy)-2-methyl-2(E)-butenal化学式
CAS
78957-45-6
化学式
C14H12O4
mdl
——
分子量
244.247
InChiKey
BOEYBMJEVSXRSZ-UXBLZVDNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    52.6
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Regiocontrolled Formation of 4,5-Dihydro-3(2<i>H</i>)-furanones from 2-Butyne-1,4-diol Derivatives. Synthesis of Bullatenone and Geiparvarin
    作者:Hiroyuki Saimoto、Tamejiro Hiyama、Hitosi Nozaki
    DOI:10.1246/bcsj.56.3078
    日期:1983.10
    Two new methods for selective hydration of 1,1,4-trisubstituted 2-butyne-1,4-diols (1) to give 4,5-dihydro-3(2H)-furanone derivatives are reported. The first involves selective monoacetylation of the less hindered hydroxyl group of 1 followed by Ag(I)-catalyzed rearrangement and cyclization to give 3-acetoxy-2,2,5-trisubstituted 2,5-dihydrofurans (2). Final hydrolysis yielded 2,2,5-trisubstituted 4
    报告了两种新方法,用于选择性合 1,1,4-三取代的 2-丁炔-1,4-二醇 (1) 以生成 4,5-二氢-3(2H)-呋喃酮生物。第一个涉及 1 的受阻较小的羟基的选择性单乙酰化,然后是 Ag(I) 催化的重排和环化,得到 3-乙酰氧基-2,2,5-三取代的 2,5-二氢呋喃 (2)。最后解产生2,2,5-三取代的4,5-二氢-3(2H)-呋喃酮。用2,3-二氯-5,6-二氰基-1,4-苯醌氧化烯醇乙酸酯2,得到3(2H)-呋喃酮。新方法用于从相应的 2-丁炔-1,4-二醇生物合成天然存在的 3(2H)-呋喃酮,如布拉藤酮和 Geiparvarin。第二种方法涉及相反区域异构体 2,5,5-三取代的 4,5-二氢-3(2H)-呋喃酮的合成,
  • Regiocontrolled hydration of 2-butyne-1,4-diol derivatives to give 4,5-dihydro-3(2H)-furanones. Practical synthesis of bullatenone and geiparvarin
    作者:Hiroyuki Saimoto、Tamejiro Hiyama、Hitosi Nozaki
    DOI:10.1021/ja00406a066
    日期:1981.8
  • Geiparvarin Analogues: Synthesis and Anticancer Evaluation ofα-Methylidene-γ-butyrolactone-Bearing Coumarins
    作者:Yeh-Long Chen、Tai-Chi Wang、Cherng-Chyi Tzeng、Nein-Chen Chang
    DOI:10.1002/(sici)1522-2675(19990210)82:2<191::aid-hlca191>3.0.co;2-p
    日期:1999.2.10
    To determine some of the structural features of geiparvarin that account for its cytostatic activity in vitro, certain geiparvarin analogues modified in the furan-3(2H)-one moiety and the alkenyloxy substituent were synthesized and tested against the growth of 60 human cancer cell lines derived from nine cancer-cell types. These compounds demonstrated a strong growth-inhibitory activity against leukemia cell lines but were relatively inactive against non-small-cell lung cancers and CNS cancers. Comparison of the mean log GI, values of gamma-[(E)-1-methylprop-1-enyl]-alpha-methylidene-gamma-butyrolactones 7-9 revealed that 7-[(E)-3-(2,3,4,5-tetrahydro-4-methylidene-5-oxofuran-2-yl)but-2-enyloxy]-2H-1-benzopyran-2-one (8: - 5.47) was more active than its 6-substituted counterpart 7 (- 5.21) and its 3-chloro-4-methyl derivative 9 (- 5.31) and had a potency similar to that of geiparvarin (log GI(50) = - 5.41). These results indicated that the furan-3(2H)-one moiety of geiparvarin could be replaced by an alpha-methylidene-gamma-butyrolactone unit without losing the anticancer potency, (:nd that the best substitution site at the coumarin moiety was C(7). The alkenyloxy substituent of 8 was also replaced by a methoxy substituent. Among these alpha-methylidene-gamma-butyrolactones, 7-[(2,3,4,5-tetrahydro-4-methylidene-5-oxo-2-phenyliuran-2-yl)methoxy]-2H-1-benzopyran-2-one (1l) was the most potent with a mean log GI(50) value of - 5.83 and a range value of 132(10(212)).
  • INOUE, Y.;OHUCHI, K.;IMAIZUMI, S.;HAGIWARA, H.;UDA, H., SYNTH. COMMUN., 20,(1990) N9, C. 3063-3068
    作者:INOUE, Y.、OHUCHI, K.、IMAIZUMI, S.、HAGIWARA, H.、UDA, H.
    DOI:——
    日期:——
查看更多